Antibody-Based Cancer Therapies banner

The pursuit of more effective and targeted cancer therapies is spurring the evolution of antibody-based treatments. At the Antibody-based Cancer Therapies conference, we will explore the potential of emerging antibody formats that are driving the oncology field, including novel antibody scaffolds, multispecifics, complex bioconjugates, and antibody-based cell therapies. Attendees will gain insights into the broadening therapeutic landscape that includes protein degraders, immunocytokines, and nucleic acids, while witnessing the power of combination therapies that are pushing the boundaries of cancer treatment.

Recommended Short Course*
Monday, 4 November, 14:00 – 17:00
SC6: Introduction to Immunogenicity of Biotherapeutics
*Separate registration required. See short courses page for details. All short courses take place in-person only.






For more details on the conference, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5439
Email: mlangley@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com